This 37% gain bodes well for you

Eli Lilly’s shares haven’t just bounced back from their drop during the March market meltdown. In fact, they’ve soared to new all-time highs for investors and are now up a stellar 36.7% over the last year.
What has spurred this strong performance? Well, it’s a combination… Read More